DNA methylation differs between idiopathic Parkinson Disease and Healthy Control subjects in the Parkinson's Progression Marker Initiative (PPMI) cohort
| Autor: | Paulina Gonzalez-Latapi MD, MSc, Bernabe Bustos, PhD, Tanya Simuni, MD, Steven Lubbe, PhD, Dimitri Krainc MD, PhD |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| DOI: | 10.5281/zenodo.7149899 |
| Popis: | The objective of this study was to compare baseline whole blood DNA methylation in unmedicated sporadic Parkinson Disease (sPD) and healthy control (HC) participants from PPMI. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|